title: Products of the reaction of selenite with intracellular sulfhydryl compounds.
abstract: The usual first step in the intracellular metabolism of exogenous selenite is its chemical reaction with glutathione to form selenodiglutathione (1). We have investigated whether selenite also reacts intracellularly with other SH compounds. HeLa cells were exposed to [75Se]selenite and lysed with SDS. Cellular proteins and nucleic acids were precipitated with trichloroacetic acid, and the acid-soluble fraction was analyzed by ion-exchange thin-layer chromatography (ion-exchange TLC) and autoradiography. In control cells, the major [75Se]-containing species detected can be identified by its mobility as selenodiglutathione. Two other species were detected, which can be identified as selenodimercaptoethylamine and the mixed selenotrisulfide of mercaptoethylamine and glutathione. In contrast, in cells that were depleted of glutathione (by treatment with buthionine sulfoximine), very little, if any, selenodiglutathione was detected. However, new [75Se]-containing species were detected, which can be identified as selenodicysteine and the mixed selenotrisulfide of cysteine and glutathione. The same species were detected when [75Se]selenite was added to the acid-soluble fraction of a cell extract (as opposed to living cells), confirming that these compounds can be formed by nonenzymatic reactions.
authors.affiliation: Department of Biological Sciences, Rutgers University, Newark, NJ 07102.
authors.forename: G D
authors.initials: GD
authors.lastname: Frenkel
authors.forename: D
authors.initials: D
authors.lastname: Falvey
authors.forename: C
authors.initials: C
authors.lastname: MacVicar
mesh_terms: D000963:Antimetabolites / Q000494:pharmacology; D001345:Autoradiography; D019328:Buthionine Sulfoximine; D002852:Chromatography, Ion Exchange; D002855:Chromatography, Thin Layer; D003545:Cysteine / Q000031:analogs & derivatives / Q000378:metabolism; D005978:Glutathione / Q000172:deficiency; D006367:HeLa Cells; D006801:Humans; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000494:pharmacology; D016566:Organoselenium Compounds / Q000378:metabolism; D020887:Selenious Acid; D012643:Selenium / Q000378:metabolism*; D018036:Selenium Compounds; D012644:Selenium Radioisotopes; D017279:Selenocysteine; D013438:Sulfhydryl Compounds / Q000378:metabolism*; D013440:Sulfides / Q000378:metabolism
chemical_list: D000963:Antimetabolites; D016566:Organoselenium Compounds; D018036:Selenium Compounds; D012644:Selenium Radioisotopes; D013438:Sulfhydryl Compounds; D013440:Sulfides; C059755:selenotrisulfide; D017279:Selenocysteine; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D020887:Selenious Acid; D005978:Glutathione; D012643:Selenium; D003545:Cysteine